PROLOR Biotech, Inc. (PBTH) [Rocket]

Overview

PROLOR Biotech, Inc. (PBTH)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Price:	$8.23			Metrics
OS:	63.9	M		-448	% ROE
Market cap:	$526	M		-1876	% ROIC
Net cash:	$24.2	M		$0.38	per share
EV:	$501	M

TTM Valuation
EBITDA	($97.8)	M
EBIT	($98.1)	M
EPS

Recent News + Filings (All items)

Date Filed	Type	Description
09/10/2013	EFFECT	Form EFFECT - Notice of Effectiveness
09/09/2013	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/06/2013	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
09/06/2013	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
09/06/2013	POS AM	Form POS AM - Post-Effective amendments for registration statement
09/03/2013	4	HAVRON ABRAHAM (CEO) has filed a Form 4 on PROLOR Biotech, Inc.
09/03/2013	4	STERN ADAM K (Director) has filed a Form 4 on PROLOR Biotech, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08
Revenues	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	3.0	2.8	2.5	14.9	0.0
Gross profit	-3.0	-2.8	-2.5	-14.9	0.0
Research and development				5.6
General and administrative	3.4	3.2	2.4	1.9	2.4
EBIT	-18.4	-14.8	-7.7	-7.5	-7.2
Pre-tax income	-18.3	-15.1	-7.6	-7.5	-7.0
Income taxes	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-18.3	-15.1	-7.6	-7.5	-7.0

Diluted EPS	($0.30)	($0.29)	($0.19)	($0.21)	$0.00
Shares outstanding (diluted)	60.2	52.0	40.0	35.5	35.5

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy